1-4 of 4
Stefano Volpetti, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Eltrombopag As Second Line Therapy in Adult Patients with Primary Immune Thrombocytopenia (ITP) in Attempt to Achieve Long-Term Remission. Preliminary Analysis of a Phase II, Multicenter, Prospective Study By Gimema Group (the ESTIT Study)

Elisa Lucchini, MD, Francesca Palandri, PhD MD, Stefano Volpetti, MD, Nicola Vianelli, MD, Giuseppe Auteri, MD, Elena Rossi, MD, Andrea Patriarca, MD, Giuseppe Carli, MD, Wilma Barcellini, MD, Patrizia Tosi, MD, Ugo Consoli, MD, Federica Valeri, MD, Cristina Santoro, MD PhD, Francesca Paoloni, Paola Fazi, MD, Elena Boggio, PhD, Umberto Dianzani, MD PhD, Ilaria Giardini, Monica Carpenedo, Renato Fanin, MD, Francesco Zaja, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1135.
https://doi.org/10.1182/blood-2018-99-113314
Published: 2018
Journal Articles

The Engineered MIPI (e-MIPI), a Candidate Data-Mining Based Mantle Cell Lymphoma Prognostic Index Developed from the Dataset of the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial

Gian Maria Zaccaria, PhD, Simone Ferrero, MD, Roberto Passera, PhD, Andrea Evangelista, PhD, Mariella Loschirico, MD, Irene Dogliotti, MD, Marco Ghislieri, Elisa Genuardi, PhD, Riccardo Bomben, PhD, Valter Gattei, MD, Giovannino Ciccone, Monica Tani, MD, Gianluca Gaidano, MD PhD, Stefano Volpetti, MD, Maria Giuseppina Cabras, MD, Nicola Di Renzo, MD, Francesco Merli, MD, Daniele Vallisa, MD, Michele Spina, MD, Anna Pascarella, MD, Giancarlo Latte, MD, Caterina Patti, Gabriele Pozzato, MD, Alberto Fabbri, MD, Sergio Cortelazzo, MD, Marco Ladetto
Journal: Blood
Blood (2018) 132 (Supplement 1): 2890.
https://doi.org/10.1182/blood-2018-99-114168
Published: 2018
Journal Articles

Multicenter Phase II Trial Addressing Lenalidomide Maintenance in Patients with Relapsed Diffuse Large B-Cell Lymphoma (rDLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT): Efficacy and Safety Results after a Median Follow-up of Five Years

Andres JM Ferreri, MD, Marianna Sassone, MD, Francesco Zaja, MD, Alessandro Re, MD, Michele Spina, MD, Alice Di Rocco, Alberto Fabbri, MD, Piera Angelillo, MD, Caterina Stelitano, MD, Maurizio Frezzato, MD, Chiara Rusconi, Renato Zambello, MD, Annalisa Arcari, MD, Giovanni Bertoldero, MD, Daniela De Lorenzo, BD, Eloise Scarano, Stefano Volpetti, MD, Salvatore Perrone, MD, Teresa Calimeri, MDPhD, Caterina Cecchetti, MD, Fabio Ciceri, MD, Maurilio Ponzoni, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1688.
https://doi.org/10.1182/blood-2018-99-116060
Published: 2018
Journal Articles

LONG-TERM Outcome of a Fondazione Italiana Linfomi Study Comparing Short Rituximab Maintenance Vs Observation after Brief First-LINE R-FND Chemoimmunotherapy Followed By Rituximab Consolidation in Elderly Patients with Advanced Follicular Lymphoma (FL)

Carola Boccomini, MD, Marco Ladetto, MD, Francesca Dutto, Simone Ferrero, MD, Luca Baldini, MD, Chiara Bottelli, MD, Claudia Castellino, MD, Annalisa Chiarenza, MD, Annarita Conconi, MD, Federico De Angelis, MD, Andrea Evangelista, Stefan Hohaus, MD, Francesco Merli, MD, Benedetta Puccini, MD, Chiara Rusconi, MD, Eleonora Russo, MD, Stefano Sacchi, MD, Stefano Volpetti, MD, Giuseppe Rossi, MD, Umberto Vitolo, MD
Journal: Blood
Blood (2015) 126 (23): 3985.
https://doi.org/10.1182/blood.V126.23.3985.3985
Published: 2015